All About Heart And Blood Vessels

What is Platypnea-Orthodeoxia Syndrome?

YouTube video player

Platypnea-orthodeoxia syndrome (POS) is a rare clinical condition characterized by dyspnea (platypnea) and arterial desaturation (orthodeoxia) that occur in the upright position and resolve when the person is supine.

For POS to occur, two distinct components must be present simultaneously:

  1. An anatomical defect: A communication allowing a right-to-left shunt (most commonly interatrial).
  2. A functional component: A condition that mechanically promotes flow across this defect specifically when the patient assumes an upright posture.

Pathophysiology

The most common etiology is cardiac, primarily involving a patent foramen ovale (PFO), an atrial septal defect (ASD), or an atrial septal aneurysm. In a normal heart, right atrial pressures are lower than left atrial pressures, keeping the PFO flap closed. However, in POS, a right-to-left shunt occurs without the strict need for elevated right heart pressures, though decreased right ventricular compliance can contribute.

Instead, postural changes alter the cardiac geometry. When the patient stands, the spatial relationship between the inferior vena cava (IVC) and the interatrial septum shifts.

The functional component essentially redirects the column of deoxygenated venous return from the IVC directly toward the septal defect. Common triggers that alter this geometry include:

Pulmonary Causes

While cardiac shunting is the most frequent cause, POS can also be driven by pulmonary pathology:

Diagnostic Workup

The diagnosis hinges on demonstrating the postural dependency of the shunt and the hypoxemia:

Management

For cardiac POS, percutaneous closure of the PFO or ASD is highly effective. It is generally considered the definitive treatment and often results in immediate and dramatic resolution of symptoms, provided there is no severe irreversible pulmonary hypertension. For pulmonary causes, management is directed at the underlying disease (e.g., liver transplantation for hepatopulmonary syndrome, or percutaneous embolization of pulmonary AVMs).

Exit mobile version